Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Idenix
Company Monitoring Page for Idenix
latest headlines for company on cafepharma
Merck “More Formidable” Competitor for Gilead, But Still Years Away
Barron's
Mon, 06/9/14 - 11:58 am
Tags:
Merck
,
Gilead Sciences
,
Idenix
,
M&A
,
hepatitis C
Achillion Pharma Might be Next Hep C Takeout Target
TheStreet.com
Mon, 06/9/14 - 09:40 am
Tags:
Achillion
,
hepatitis C
,
M&A
,
JNJ
,
AbbVie
,
Merck
,
Idenix
Why Merck Just Spent $4 Billion On New Drugs For Hepatitis C
Forbes
Mon, 06/9/14 - 09:24 am
Tags:
Merck
,
hepatitis C
,
M&A
,
Idenix
Merck to Buy Hepatitis-Drug Maker Idenix
Bloomberg
Mon, 06/9/14 - 09:10 am
Tags:
Idenix
,
Merck
,
M&A
,
hepatitis C
Idenix's Q1 Loss Widens
Yahoo/Zacks.com
Mon, 05/5/14 - 09:56 am
Tags:
earnings
,
Idenix
The Baupost Group ups its stake in Idenix Pharmaceuticals
Yahoo/Market Realist
Sat, 03/15/14 - 10:01 am
Tags:
Idenix
Gilead's hot-selling Sovaldi draws more patent attacks
Fierce Pharma
Fri, 03/14/14 - 11:15 am
Tags:
Sovaldi
,
Idenix
,
Merck
,
Roche
,
hepatitis C
,
patents
,
Gilead Sciences
The 10 Most Heavily Shorted Bio-Pharma Stocks
TheStreet.com
Mon, 02/24/14 - 11:15 am
Tags:
Spectrum Pharmaceuticals
,
Dendreon
,
Achillion
,
Ziopharm
,
Intrexon
,
Arena Pharmaceuticals
,
Idenix
,
Synta Pharmaceuticals
,
Sarepta Therapeutics
,
Myriad Genetics
3 Biotech Stocks to Bet on this Earnings Season
Yahoo/Zacks.com
Thu, 02/20/14 - 08:50 am
Tags:
earnings
,
Medivation
,
United Therapeutics
,
Idenix
This Week in Biotech: Let's Get Clinical!
Motley Fool
Sun, 02/2/14 - 11:30 am
Tags:
AbbVie
,
Enanta Pharmaceuticals
,
ABT-450
,
hepatitis C
,
Medivation
,
Xtandi
,
prostate cancer
,
Astellas
,
Geron
,
imetelstat
,
PSMA-ADC
,
Progenics Pharmaceuticals
,
Idenix
Idenix Pharma CEO Speaks On Plans for the $107 Million Just Raised
TheStreet.com
Tue, 01/28/14 - 11:17 am
Tags:
Idenix
,
Pharma CEOs
,
Gilead Sciences
,
hepatitis C
,
Ron Renaud
Teva Acquisition Machine Gears Up: Who Is the Next Target?
Yahoo/24-7 Wall St
Wed, 01/22/14 - 08:41 am
Tags:
Teva Pharmaceuticals
,
M&A
,
Idenix
,
Insmed
,
NuPathe
,
InterMune
,
Puma Biotechnology
UBS Has Nine Biotech Buyout and Merger Candidates
24/7 Wall St
Tue, 01/14/14 - 09:07 am
Tags:
biotech
,
M&A
,
Alexion
,
Biomarin
,
Incyte
,
Medivation
,
Idenix
,
Insmed
,
InterMune
,
Puma Biotechnology
,
Vertex Pharmaceuticals
The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Mon, 01/13/14 - 10:12 am
Tags:
JPMHC 2014
,
GSK
,
Intercept Pharma
,
Acorda Therapeutics
,
Cell Therapeutics
,
Novartis
,
Sanofi
,
Alnylam
,
Idenix
,
Alexion
,
Galena Biopharma
,
Incyte
,
Clovis Oncology
,
Dendreon
,
Merck
,
Arena Pharmaceuticals
Idenix fires off a shot in patent battle over Gilead's sofosbuvir
Fierce Biotech
Mon, 12/2/13 - 05:04 pm
Tags:
Idenix
,
Gilead
,
sofosbuvir
,
hepatitis C
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sun, 10/13/13 - 12:06 pm
Tags:
Ariad
,
Acadia
,
Idenix
Janssen Purchase Doesn't Change Case For Idenix
Seeking Alpha
Thu, 10/10/13 - 06:17 pm
Tags:
Janssen
,
Idenix
,
IDX719
These 2 Hepatitis-C Drug Developers Are Getting Left in the Dust
Motley Fool
Mon, 09/30/13 - 10:41 am
Tags:
hepatitis C
,
Vertex Pharmaceuticals
,
Incivek
,
sovaprevir
,
Achillion
,
IDX184
,
IDX320
,
Idenix
Idenix Pharmaceuticals: Potential Multi-Bagger Means Little Risk/High Reward
Seeking Alpha
Wed, 07/31/13 - 10:13 am
Tags:
Idenix
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Sat, 07/20/13 - 11:26 am
Tags:
Gilead Sciences
,
AbbVie
,
hepatitis
,
hepatitis C
,
Bristol-Myers Squibb
,
Idenix
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.